戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (right1)

通し番号をクリックするとPubMedの該当ページを表示します
1                      The mean consensus reading grade level was similar between academic (11.73 +/- 1.68) and private (11
2                                                Pre-ICI, GLS was similar between cases and control subjects (20.3 +/- 2.6%
3                                       Although patient care was similar between conditions (b = 2.00, t (55) = 0.99, p =
4                            Graft loss at 1 month and 1 year was similar between groups (O:E = 0.65 vs 1.00, P = 0.11 and
5                                       Bone volume formation was similar between groups (P >0.05).
6                   Although total improvement in LV measures was similar between groups, Black patients averaged larger ga
7         Valve Academic Research Consortium-2 device success was similar between Sapien 3 and Evolut R/PRO (85.6% versus 8
8                                             Overall outcome was similar between the 2 groups with respect to graft and pa
9                              The frequency of serious TEAEs was similar between the groups (10% in the praliciguat group
10        Treatment failure occurred in 294 patients (38%) and was similar between time intervals from index arthroplasty to
11          The incidence of treatment-emergent adverse events was similar between treatment arms, with a low incidence of h
12                                                  Median age was similar between trials at 64 or 65 years (with IQRs rangi
13                               Rates of adverse events (AEs) were similar between both groups.
14 ally reduced across the entire sampling area and body sizes were similar between burned and unburned sites.
15                          The characteristics of the nodules were similar between CBCT and CCT guidance.
16                                      Serious adverse events were similar between groups (112 [43%] of 258 patients in the
17                                                   Residents were similar between groups by age (mean, ~79), heart failure
18 p = 0.468) and follow-up CT (26 [18] vs 19 [12]; p = 0.352) were similar between groups.
19                       AR gene alterations and AR expression were similar between groups.
20 icular hemorrhage, hydrocephalus, and thromboembolic events were similar between groups.
21 ities, ventilator dependence, and severity of acute illness were similar between groups.
22                          Although the total liver BA levels were similar between KO/KD and KO, there was significant dysr
23 s deaths per 100,000 people and relative increase in deaths were similar between men and women in most countries.
24                       Etiologies and clinical presentations were similar between men living with and without HIV.
25                                     Cusp closing velocities were similar between native roots and the SG group, and were
26 ough temperature sensitivities for bulk peat methanogenesis were similar between open-water (Q(10) = 2.1) and vegetated (
27 e renal outcomes were higher in patients with diabetes, but were similar between patients with prediabetes and normoglyce
28 us 11.7%, P = 0.8), and median LOS (5 d versus 5d, P = 0.2) were similar between pre-KAS and post-KAS recipients.
29                       Observed rates of ACGF within 3 years were similar between recipient groups (15.5% in AKI vs 15.1%
30 uantities of glycation- and oxidation-related modifications were similar between regular and hay milk and among seasons.
31                                 H3N2 and influenza B titers were similar between seasons.
32           Postoperative mortality and overall survival (OS) were similar between sexes.
33                                Relative cusp opening forces were similar between SG, Uni-Graft, and control groups, where
34          Average feedstock production emissions intensities were similar between sorghum and corn with 75% stover removal
35                         Death and organ support requirement were similar between SOT and non-SOT critically ill patients
36 ts (100% vs 50%, respectively), but other clinical features were similar between the 2 groups.
37  0.19) and biliary (16% versus 17%; P = 0.94) complications were similar between the 2 groups.
38  improvement in the least-squares mean (SE) HAM-D-24 scores were similar between the active (-11.1 [2.03]) and sham group
39           Presenting symptoms and in-hospital complications were similar between the cancer and noncancer groups.
40     All cause death, stroke, and cardiovascular event rates were similar between the groups.
41                               Graft dimensions and function were similar between the groups.
42 gents and azithromycin in neutrophils from healthy subjects were similar between the smooth and rough morphotypes of M. a
43                           Number and type of adverse events were similar between the three groups.
44                        Overall, surgical complication rates were similar between the two groups (P = 0.730).
45                                    Symptoms at presentation were similar between the two groups, although abdominal pain
46                                      Anti-F serum responses were similar between these 2 groups for antibody repertoires,
47                                    Baseline characteristics were similar between treatment arms.
48 tion (414 [90%] of 460 vs 386 [88%] of 438) assessments and were similar between treatment groups.
49                         Ratios for mortality and graft loss were similar between VA centers and their respective academic
50         The rates of local reactions related to vaccination were similar between vaccine arms (3AV vs 1AV) after the firs